UNSPSC 51413910: Piraxelate

This classification denotes a vasodilating agent with the molecular formula C15H25NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y1P25NQI7X, chemically known as 3,3,5-trimethylcyclohexyl-2-oxo-1-pyrrolidineacetate. but generally known as piraxelate, which bears US NIH Compound Identifier 3047851. European Medicines Agency schedules Piraxelate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09895MIG.

UNSPSC 51413910 Piraxelate is a Commodity code for pharmaceutical products, though recent state and local opportunities show this specific ingredient code sees minimal direct procurement activity. Instead, state and local governments are buying advanced life support medications, generic multi-source pharmaceuticals, and over-the-counter products through broader category solicitations that encompass entire medication classes rather than individual active pharmaceutical ingredients. The issuing bodies include municipal fire rescue departments (City of Tampa), state health and human services commissions (Texas HHS), and cooperative purchasing alliances serving multi-state networks (Minnesota Multistate Cooperative Purchasing Alliance, serving state and local government facilities across participating states including Oregon). Work being solicited includes sealed-bid procurement of specific medication line items with firm pricing and delivery guarantees, cooperative purchasing contracts for generic pharmaceuticals through authorized wholesalers with EDI capability and pricing format flexibility, and preliminary market intelligence gathering on direct-to-manufacturer pharmacy initiatives.

Recent activity concentrates in Texas, Minnesota, and Florida. The City of Tampa issued IFB No. 26P00188 for Advanced Life Support Medications on April 24, 2026, requiring sealed bids by April 8, 2026 for 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials with nine-month minimum expiration dates and ten-day delivery to Tampa Fire Rescue, with an estimated contract value of $40,000 and a 5 percent SLBE bid discount available. The Minnesota Department of Administration, administering MMCAP, issued an RFP due March 26, 2026 for generic multi-source pharmaceuticals and OTC products distributed across state and local government facilities, requiring vendors to supply through three authorized wholesalers (Cencora, Cardinal Health 110 and 112, and Morris & Dickson) with awarded contracts effective July 1, 2026. The Texas HHS Commission issued RFI No. HHS0017013 on March 27, 2026 to gather market intelligence on direct-to-manufacturer prescription programs, seeking vendor capabilities for direct contracting outside traditional pharmacy benefit manager and group purchasing organization arrangements. Piraxelate as a discrete code sees little recent standalone activity; procurement under related medication and pharmaceutical categories is the operational norm.